IPO Search Results for jyong biotech

Company	Ticker	Business Description	Underwriters	Offer Date
Jyong Biotech	JYB.XX	Commercial-ready Taiwanese biotech developing therapies for urinary diseases.	Joseph Stone Capital	Withdrawn
Jyong Biotech	MENS	Commercial-ready Taiwanese biotech developing therapies for urinary diseases.	Joseph Stone Capital	TBA

Showing 1 to 2 of 2 entries

News Results for jyong biotech
Urinary disease biotech Jyong Biotech sets terms for $19 million US IPO 02/06/25
US IPO Weekly Recap: Astera Labs joins the IPO calendar as more small issuers list 03/08/24
Urinary disease biotech Jyong Biotech refiles for a $29 million US IPO 03/07/24
Urinary disease biotech Jyong Biotech withdraws $40 million US IPO 12/20/23
US IPO Weekly Recap: Sezzle direct lists and a micro-cap IPO pops and drops 08/18/23
Urinary disease biotech Jyong Biotech files for a $40 million US IPO 08/17/23

Showing 1 to 6 of 6 entries